DRUG · Mapped RxNorm record
Insulin Icodec
Normalized identity: insulin icodec View linked drug · Find medicine records ·
Find other trials using this name
Clinical trial
A Study Using Flash Glucose Measurements for a New Once-weekly Insulin (Insulin Icodec) in People With Type 2 Diabetes Who Have Not Used Insulin Before (ONWARDS 9)
NCT05823948
Study summary
ClinicalTrials.govA Study Using Flash Glucose Measurements for a New Once-weekly Insulin (Insulin Icodec) in People With Type 2 Diabetes Who Have Not Used Insulin Before (ONWARDS 9)
Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE3
Loading study purpose, treatment groups and outcomes…
View the complete registry record, eligibility and contacts at ClinicalTrials.gov
Drugs and interventions used in this trial
1 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
No matching interventions in this trial.
Advertisement
Conditions
Interventions
Insulin IcodecDRUG · verified · RxNorm: insulin icodec
Sponsors & collaborators
Novo Nordisk A/Slead sponsor
Mapped research locations
DallasTexas, United States2San AntonioTexas, United States2San DiegoCalifornia, United States1MinneapolisMinnesota, United States1OrlandoFlorida, United States1Las VegasNevada, United States1SacramentoCalifornia, United States1HonoluluHawaii, United States1West Palm BeachFlorida, United States1CantonOhio, United States1WilmingtonNorth Carolina, United States1AmarilloTexas, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT05823948 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.